{"product_id":"endocrine-disruptors-part-i-von-m-metzler-hrsg","title":"Endocrine Disruptors Part I","description":"\n                                The field of endocrine disruption or endocrine active compounds (EACs), which is just emerging and still controversial, is comprehensively covered by leading experts in \n                \n                \u003cb\u003eVolume 3\u003c\/b\u003e\n                                , \n                \n                \u003cb\u003eSubvolumes L\u003c\/b\u003e\n                                 (the present volume, Part I) and \n                \n                \u003cb\u003eM\u003c\/b\u003e\n                                 \n                \n                \u003cb\u003e(Part II). The major classes of endocrine active chemicals \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003eare discussed, as well as methods for their detection and \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003etheir association with health disturbances in humans and \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003ewildlife. The etiology of several of the human diseases \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003eassociated with endocrine disruptors, e.g. breast and \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003eprostate cancer, decreased fertility and malformations, is \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003estill poorly understood, and the current state of knowledge \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003eis presented. Since hormonally active agents appear to have \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003ethe potential of both adverse and beneficial effects, the \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003eevidence of health benefits associated with endocrine active\u003c\/b\u003e\n                                 \n                \n                \u003cb\u003ecompounds in humans is also presented. Basic chapters on the\u003c\/b\u003e\n                                 \n                \n                \u003cb\u003emode of action of EACs and on the etiology of the associated\u003c\/b\u003e\n                                 \n                \n                \u003cb\u003ediseases facilitate the understanding of this complex \u003c\/b\u003e\n                                 \n                \n                \u003cb\u003esubject for non-medical readers. \u003c\/b\u003e\n                            \n            \u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9783662146811\"\u003e\u003ch3\u003e\u003c\/h3\u003e\u003c\/div\u003e","brand":"Libri","offers":[{"title":"Softcover - 9783662146811","offer_id":39425984790621,"sku":"9783662146811","price":106.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/cd7594ac-6579-4ce3-b856-1248c750fb5b.jpg?v=1772085240","url":"https:\/\/shop.autorenwelt.de\/en\/products\/endocrine-disruptors-part-i-von-m-metzler-hrsg","provider":"Autorenwelt Shop","version":"1.0","type":"link"}